"To date, NNZ-2566 appears to be well-tolerated. The serious adverse events (SAEs) reported among study subjects have been typical for critically injured patients and the mortality rate is substantially below that reported in comparable trials."
#######
If they are talking about NNZ study subjects and not placebo then this is potentially a massively positive sign.
Does substantially mean statistically significant?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.55 |
Change
0.540(3.17%) |
Mkt cap ! $2.211B | |||
| Open | High | Low | Value | Volume |
| $17.48 | $18.44 | $17.40 | $16.43M | 922.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2624 | $17.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.70 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |